| Literature DB >> 10492522 |
G Tunnicliff1, N L Schindler, G J Crites, R Goldenberg, A Yochum, E Malatynska.
Abstract
The clinically important antidepressant fluoxetine is established as a selective serotonin reuptake inhibitor. This study demonstrates that fluoxetine also interacts with the GABA(A) receptor complex. At concentrations above 10 microM fluoxetine inhibited the binding of both [3H]GABA (IC50 = 2 mM) and [3H]flunitrazepam (IC50 = 132 microM) to the GABA(A) receptor complex in brain cortical membranes. Low fluoxetine concentrations (1 nM) enhanced GABA-stimulated Cl- uptake by a rat cerebral cortical vesicular preparation. At higher concentrations (100 microM and 1 mM), however, fluoxetine inhibited GABA-stimulated Cl- uptake, an effect related to a reduction in Emax. These observations might assist in an explanation of the basis of the antidepressant action of fluoxetine.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10492522 DOI: 10.1023/a:1020977123968
Source DB: PubMed Journal: Neurochem Res ISSN: 0364-3190 Impact factor: 3.996